Tirzepatide Side Effects
Tirzepatide (Mounjaro / Zepbound) side effects mirror the GLP-1 class - GI-dominant and titration-linked - with a generally similar profile to semaglutide despite the added GIP activity.
When they appear & how long they last
Like semaglutide, GI effects cluster around dose increases and settle within 1-2 weeks at a steady dose. The 5mg -> 15mg titration ladder is where most users feel the turbulence; many find their tolerable plateau at 5-10mg.
Commonly reported Tirzepatide side effects
Most common effect; tends to be milder than equivalent semaglutide doses for many users.
Motility shifts in either direction during titration.
The intended effect; watch for under-eating and muscle loss during rapid loss.
Mild local redness or itching.
Often calorie-deficit-driven rather than direct.
From slowed gastric emptying.
When to contact your provider
- Severe abdominal pain radiating to the back - pancreatitis warning sign
- Gallbladder symptoms - upper-right pain, fever, jaundice
- Persistent vomiting with dehydration
- Rapid muscle/strength loss (track lean mass, not just scale weight)
- Allergic-reaction signs (swelling, breathing difficulty)
Biomarkers worth tracking on Tirzepatide
These catch issues early - before you feel them. Pull a baseline before you start, then re-check on the cadence noted below.
Tirzepatide drives large insulin-sensitivity gains; this confirms it.
Tracks glycemic response across 90-day windows.
Cardiovascular-risk marker that often improves with the metabolic shift.
How to actually track Tirzepatide side effects
The tirzepatide titration ladder makes a dose-vs-symptom timeline especially useful: log the dose-increase date and the GI response, and the tolerance pattern becomes predictable. Because lean-mass loss is a real risk during rapid weight loss, pair the scale with body-composition and a protein-intake note so the loss is fat, not muscle.
Track Tirzepatide with MyProtocolStack →